Renovorx, Inc. (RNXT)

Trade RNXT now with
7/19/2022 8:33:06 AM RenovoRx Appoints James Ahlers As CFO, Effective July 15
5/16/2022 7:54:14 AM RenovoRx Q1 Net Loss $3.0 Mln Vs Loss $1.1 Mln Prior Year
3/30/2022 8:40:15 AM RenovoRx FY Net Loss $6.3 Mln Vs. Loss Of $3.8 Mln Prior Year
11/11/2021 6:08:45 AM RenovoRx To Present Final Data From RR2 Observational Registry Study At 2021 Pancreas Club Annual Meeting
11/10/2021 12:03:43 PM Why Is RenovoRx Stock Up 67%?
9/7/2021 6:05:57 AM RenovoRx Gets New 510(k) Clearance From FDA For RenovoCath® Delivery System For Solid Tumors